- Report
- July 2025
- 250 Pages
Latin America
From €3401EUR$3,869USD£2,942GBP
- Report
- July 2025
- 250 Pages
Asia Pacific
From €3401EUR$3,869USD£2,942GBP
- Report
- July 2025
- 250 Pages
Europe
From €3401EUR$3,869USD£2,942GBP
- Report
- February 2025
- 103 Pages
Europe
From €5269EUR$5,995USD£4,558GBP
- Report
- February 2025
- 73 Pages
North America
From €5269EUR$5,995USD£4,558GBP
- Report
- July 2025
- 250 Pages
North America
From €3401EUR$3,869USD£2,942GBP
- Report
- June 2025
- 182 Pages
United States
From €5269EUR$5,995USD£4,558GBP
- Report
- June 2025
- 92 Pages
Europe
From €3472EUR$3,950USD£3,003GBP
- Report
- May 2025
- 76 Pages
Africa, Middle East
From €2593EUR$2,950USD£2,243GBP
- Report
- May 2025
- 95 Pages
Asia Pacific
From €3032EUR$3,450USD£2,623GBP
- Report
- May 2025
- 98 Pages
Europe
From €3032EUR$3,450USD£2,623GBP
- Report
- May 2025
- 88 Pages
North America
From €2593EUR$2,950USD£2,243GBP
- Report
- October 2024
- 70 Pages
Latin America
From €835EUR$950USD£722GBP
- Report
- February 2020
- 267 Pages
Global
From €4306EUR$4,899USD£3,725GBP
- Report
- January 2020
- 473 Pages
Global
From €4306EUR$4,899USD£3,725GBP
- Report
- September 2024
- 593 Pages
Global
From €4218EUR$4,799USD£3,649GBP
- Report
- October 2018
- 450 Pages
Global
From €3076EUR$3,499USD£2,660GBP
- Report
- March 2024
- 329 Pages
Global
From €5205EUR$6,129USD£4,350GBP
- Report
- July 2024
- 288 Pages
Global
From €5205EUR$6,129USD£4,350GBP
- Report
- October 2023
- 428 Pages
Global
From €5205EUR$6,129USD£4,350GBP

Injectables and infusions are medical treatments that involve the administration of drugs or other substances directly into the body. Injectables are typically administered through a needle or syringe, while infusions are typically administered through a catheter or intravenous line. Injectables and infusions are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases.
The injectable market is a rapidly growing segment of the pharmaceutical industry. It is estimated that the global injectable market is worth over $100 billion and is expected to grow at a compound annual growth rate of over 8%. The market is driven by the increasing prevalence of chronic diseases, the growing demand for biologics, and the increasing use of self-injectable drugs.
Some of the major players in the injectable market include Pfizer, Merck, Sanofi, Novartis, and Johnson & Johnson. Other companies in the market include Amgen, Bristol-Myers Squibb, Eli Lilly, and AstraZeneca. Show Less Read more